Use of intracellular transport processes for targeted drug delivery into a specified cellular compartment

被引：0
作者：
A. A. Rosenkranz
A. V. Ulasov
T. A. Slastnikova
Y. V. Khramtsov
A. S. Sobolev
机构：
[1] Russian Academy of Sciences,Institute of Gene Biology
[2] Lomonosov Moscow State University,Faculty of Biology
[3] Targeted Delivery of Pharmaceuticals “Translek” LLC,undefined
来源：
Biochemistry (Moscow) | 2014年 / 79卷
关键词：
targeted drug delivery; intracellular transport; receptor-mediated endocytosis; transport of macromolecules; nuclear import; modular nanotransporters; cancer therapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Targeted drug delivery into the cell compartment that is the most vulnerable to effects of the corresponding drug is a challenging problem, and its successful solution can significantly increase the efficiency and reduce side effects of the delivered therapeutic agents. To accomplish this one can utilize natural mechanisms of cellular specific uptake of macromolecules by receptor-mediated endocytosis and intracellular transport between cellular compartments. A transporting construction combining the components responsible for different steps of intracellular transport is promising for creating multifunctional modular constructions capable of delivering the necessary therapeutic agent into a given compartment of type-specified cells. This review focuses on intracellular transport peculiarities along with approaches for designing such transporting constructions for new, more effective, and safer strategies for treatment of various diseases.
引用
收藏
页码：928 / 946
页数：18
相关论文
共 983 条
[1]  
D’Souza G G(2009)Subcellular targeting: a new frontier for drug-loaded pharmaceutical nanocarriers and the concept of the magic bullet Expert. Opin. Drug Deliv. 6 1135-1148
[2]  
Weissig V(2010)Subcellular targeting strategies for drug design and delivery Nat. Rev. Drug Discov. 9 29-42
[3]  
Rajendran L(2007)Endocytic mechanisms for targeted drug delivery Adv. Drug Deliv. Rev. 59 748-758
[4]  
Knolker H J(2009)Novel modular transporters delivering anticancer drugs and foreign DNA to the nuclei of target cancer cells J. BUON 14 S33-S42
[5]  
Simons K(2013)Protein-protein interactions: general trends in the relationship between binding affinity and interfacial buried surface area Protein Sci. 22 510-515
[6]  
Bareford L M(1999)The atomic structure of protein-protein recognition sites J. Mol. Biol. 285 2177-2198
[7]  
Swaan P W(2013)Modular nanocarriers as a multipurposed platform for delivery of anticancer drugs Vestn. Ros. Akad. Nauk 83 685-697
[8]  
Sobolev A S(1998)Selective gene transfer into the liver of non-human primates with E1-deleted, E2A-defective, or E1-E4 deleted recombinant adenoviruses Hum. Gene Ther. 9 671-679
[9]  
Chen J(2008)Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients J. Clin. Invest. 118 3143-3150
[10]  
Sawyer N(2006)Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response Nat. Med. 12 342-347
12345678910